CCM
BSX icon

Coldstream Capital Management’s Boston Scientific BSX Stock Holding History

Coldstream Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Sell
36,371
-1,254
-3% -$100K 0.03% 264
2025
Q4 		$3.59M Sell
37,625
-5,887
-14% -$577K 0.05% 185
2025
Q3 		$4.25M Buy
43,512
+5,839
+15% +$605K 0.06% 168
2025
Q2 		$4.05M Buy
37,673
+6,811
+22% +$689K 0.07% 164
2025
Q1 		$3.11M Buy
30,862
+1,230
+4% +$124K 0.07% 168
2024
Q4 		$2.65M Buy
29,632
+2,306
+8% +$203K 0.06% 194
2024
Q3 		$2.3M Buy
27,326
+2,346
+9% +$185K 0.05% 211
2024
Q2 		$1.92M Buy
24,980
+7,431
+42% +$544K 0.05% 214
2024
Q1 		$1.2M Buy
17,549
+37
+0.2% +$2.38K 0.03% 290
2023
Q4 		$1.01M Buy
17,512
+713
+4% +$38.1K 0.03% 293
2023
Q3 		$887K Sell
16,799
-412
-2% -$21.6K 0.03% 280
2023
Q2 		$931K Buy
17,211
+279
+2% +$14.6K 0.03% 283
2023
Q1 		$847K Buy
16,932
+1,072
+7% +$50.5K 0.03% 299
2022
Q4 		$734K Buy
+15,860
New +$687K 0.03% 319
2022
Q2 		$481K Buy
12,901
+1,123
+10% +$45.7K 0.02% 404
2022
Q1 		$522K Sell
11,778
-213
-2% -$9.23K 0.02% 365
2021
Q4 		$509K Buy
11,991
+5,687
+90% +$239K 0.02% 420
2021
Q3 		$241K Buy
6,304
+496
+9% +$21.9K 0.01% 348
2021
Q2 		$248K Buy
+5,808
New +$244K 0.01% 443
2021
Q1 		– Sell
-6,027
Closed -$217K – 445
2020
Q4 		$217K Buy
+6,027
New +$217K 0.01% 371
2020
Q1 		– Sell
-5,096
Closed -$231K – 290
2019
Q4 		$231K Buy
+5,096
New +$213K 0.02% 302
2019
Q3 		– Sell
-4,914
Closed -$211K – 335
2019
Q2 		$211K Buy
+4,914
New +$189K 0.02% 301

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Coldstream Capital Management's BSX Position: Q1 2026 in Review

Coldstream Capital Management reduced its Boston Scientific (BSX) stake by 3.3% in Q1 2026, selling an estimated $100K and leaving 36,371 shares worth $2.28M. The position accounts for 0.03% of the portfolio, ranked #264.

Coldstream Capital Management first reported a position in BSX in Q2 2019 and has held it in 22 quarters since. The position peaked at $4.25M in Q3 2025. 1,673 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Coldstream Capital Management held 36,371 shares of Boston Scientific worth $2.28M as of Q1 2026.
  • Coldstream Capital Management sold 1,254 Boston Scientific shares in Q1 2026, an estimated $100K.
  • Boston Scientific made up 0.03% of Coldstream Capital Management's portfolio in Q1 2026, its #264 holding.
  • Coldstream Capital Management first reported a position in Boston Scientific in Q2 2019 and has held it in 22 quarters since.
  • Coldstream Capital Management's Boston Scientific position peaked at $4.25M in Q3 2025.
  • 1,673 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.